Alzheimer's Research UK Drug Discovery
In this podcast we welcome academics and industry to discuss the Dementia Consortium and drug discovery, from the basics of target validation to the question you always wanted to ask big pharma - what is their motivation for investing!\n\nThe panel is made up of Dr Declan Jones and Dr John Isaac both from Johnson & Johnson, one of the seven industry partners of the Dementia Consortium, Professor Paul Whiting, the CSO at the Drug Discovery Institute at UCL and James Connell the Research Manager at Alzheimer's Research UK who coordinates the Dementia Consortium.\n\nThe Dementia Consortium is a private-charity partnership between Alzheimer\u2019s Research UK, Evotec and the pharmaceutical companies Abbvie, Astex Pharmaceuticals, Eisai, Johnson & Johnson, Lilly and MSD.\n\nThe Consortium provides drug discovery resources, project management, industry expertise and tools as well as full funding support for projects. It can support small molecule or antibody-based strategies and aims to generate tools to achieve preclinical target validation. The ultimate goal is to progress successful projects from laboratories towards the clinic.\n\nYou can find out more about the Dementia Consortium here, including details of their funding programmes throughout the year:\nhttps://www.dementiaconsortium.org/\n\nYou can find out more about our panellists, and their work on our website www.dementiaresearcher.nihr.ac.uk. A transcript of this podcast is also available on our website at https://www.dementiaresearcher.nihr.ac.uk/podcast-alzheimers-research-uk-drug-discovery\n\nLike what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode.\n\n_________________________\n\nIf you would like to share your own experiences or discuss your research in a blog or on a podcast, drop us a line to adam.smith@nihr.ac.uk or find us on twitter @dem_researcher\n\n_________________________\n\nJoin Dementia Research a topic of a previous podcast has been selected as a Top 100 innovation created by University College London. The overall winner will be decided by a public vote. It would be great if you could show your support by voting for them by hitting the thumbs up on this page - https://www.ucl.ac.uk/made-at-ucl/stories/join-dementia-research-getting-public-involved\n\nThank you